drugset / Trial / NCT00398216

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

NCT00398216

Phase 2 Completed 903 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindPrevention

Summary

This study is to assess if DU176b is effective in prevention of blood clots following hip replacement surgery. The duration is 7-10 days of treatment and 30 and 60 day follow-up visits.

Timeline

Start
2006-05
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Edoxaban Small molecule

Indications